Vastagbélrák: vizsgálatok itt: Szingapúr

In Szingapúr 14 Also abroad 1930

14 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Where
Singapore
Életkor
18 év and over
People
477 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06997497 · EU 2024-517232-22-00
1/2. fázisTaking people
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Where
Singapore
Életkor
18 év and over
People
160 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00
2/3. fázisTaking people
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Where
Singapore
Életkor
18 év and over
People
990 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07221357 · EU 2025-523224-45-00
2. fázisTaking people
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Where
Singapore
Életkor
18 év and over
People
140 worldwide
Run by
Vividion Therapeutics, Inc.
See details and how to joinNCT07811193 · EU 2026-525507-26-00
1. fázisTaking people
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Where
Singapore
Életkor
18 év and over
People
180 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07261631
1. fázisTaking people
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
Where
Singapore
Életkor
18 év and over
People
130 worldwide
Run by
Bayer
See details and how to joinNCT07535112 · EU 2025-523648-11-00
1/2. fázisTaking people
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Where
Kent Ridge, Singapore
Életkor
12 év and over
People
300 worldwide
Run by
PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750
No phaseNot yet taking people in Szingapúr
Mailed FIT-Based Outreach Interventions
Where
Singapore
Életkor
50 év to 80 év
People
40 000
Run by
National Cancer Centre, Singapore
See details and how to joinNCT07852793
2. fázisTaking people
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
Where
Singapore
Életkor
21 év and over
People
60
Run by
National Cancer Centre, Singapore
See details and how to joinNCT04912765
1/2. fázisTaking people
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Where
Singapore
Életkor
18 év and over
People
180 worldwide
Run by
Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00
No phaseTaking people
AP-NOSES: A Prospective Multicentre Registry of Natural Orifice Specimen Extraction in Minimally Invasive Colorectal Surgery
Where
Singapore
Életkor
21 év and over
People
800
Run by
Singapore General Hospital
See details and how to joinNCT07615036
1/2. fázisTaking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Singapore
Életkor
12 év and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
2. fázisTaking people
Neoadjuvant ADG126 and Pembrolizumab in Locally Advanced Colorectal Cancer
Where
Singapore
Életkor
21 év and over
People
20
Run by
National University Hospital, Singapore
See details and how to joinNCT06846268
2. fázisTaking people
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Where
Singapore
Életkor
18 év and over
People
497 worldwide
Run by
Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00